tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SNY Stock Latest News

Morning Movers: Intel slipping ahead of holiday shortened-session
The FlyMorning Movers: Intel slipping ahead of holiday shortened-session
4d ago
NKE
SNY
Dynavax jumps 37% to $15.31 after buyout offer from Sanofi
PremiumThe Fly
Dynavax jumps 37% to $15.31 after buyout offer from Sanofi
4d ago
SNY
DVAX
Sanofi to acquire Dynavax for $15.50 per share in cash, or $2.2B
PremiumThe Fly
Sanofi to acquire Dynavax for $15.50 per share in cash, or $2.2B
4d ago
SNY
DVAX
Sanofi (SNY) Acquires Dynavax in $2.2 Billion Deal after FDA Rebuff
PremiumMarket News
Sanofi (SNY) Acquires Dynavax in $2.2 Billion Deal after FDA Rebuff
4d ago
SNY
DVAX
Sanofi Wins EMA Orphan Designation for Efdoralprin Alfa in Rare Emphysema
PremiumCompany Announcements
Sanofi Wins EMA Orphan Designation for Efdoralprin Alfa in Rare Emphysema
5d ago
6K
SNY
MSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
PremiumMarket NewsMSFT, CRM, ORCL: Why Evercore Names These 3 Software Stocks as ‘Top Picks for 2026’
5d ago
AZN
CRM
Sanofi announces European Commission approval of Wayrilz
Premium
The Fly
Sanofi announces European Commission approval of Wayrilz
5d ago
SNY
Regeneron, Sanofi get marketing authorization for Dupixent from MHLW in Japan
Premium
The Fly
Regeneron, Sanofi get marketing authorization for Dupixent from MHLW in Japan
5d ago
SNY
REGN
Sanofi Strikes Three-Year US Drug Pricing and Tariff Deal with Trump Administration
PremiumCompany Announcements
Sanofi Strikes Three-Year US Drug Pricing and Tariff Deal with Trump Administration
5d ago
6K
SNY
Government deals lift overhang on pharma group, says BofA
PremiumThe Fly
Government deals lift overhang on pharma group, says BofA
6d ago
AZN
BMY
The Week That Was, The Week Ahead: Macro & Markets, Dec. 20
PremiumMarket News
The Week That Was, The Week Ahead: Macro & Markets, Dec. 20
6d ago
CI
CL
Trump announces pacts with nine pharma companies to lower drug prices
PremiumThe Fly
Trump announces pacts with nine pharma companies to lower drug prices
8d ago
BMY
GSK
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
PremiumThe FlyDrugmakers set to make deals with Trump in exchange for incentives, WaPo reports
8d ago
AZN
BMY
Sanofi Expands Real‑World Atopic Dermatitis Data With Global Long‑Term Registry
Premium
Company Announcements
Sanofi Expands Real‑World Atopic Dermatitis Data With Global Long‑Term Registry
10d ago
SNY
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
Premium
Market News
Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard
10d ago
AZN
CRM
Sanofi Faces Delay in FDA Review for Tolebrutinib in MS
PremiumCompany Announcements
Sanofi Faces Delay in FDA Review for Tolebrutinib in MS
13d ago
6K
SNY
Sanofi anticipates delay in U.S. regulatory review of tolebrutinib in nrSPMS
PremiumThe Fly
Sanofi anticipates delay in U.S. regulatory review of tolebrutinib in nrSPMS
13d ago
SNY
Sanofi says tolebrutinib did not meet primary endpoint in PERSEUS phase 3 study
PremiumThe Fly
Sanofi says tolebrutinib did not meet primary endpoint in PERSEUS phase 3 study
13d ago
SNY
Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks
PremiumRatings
Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks
13d ago
SNY
Sanofi Expands Vaccine Portfolio and Gains China Approval for Rare Disease Drugs
PremiumCompany AnnouncementsSanofi Expands Vaccine Portfolio and Gains China Approval for Rare Disease Drugs
15d ago
6K
SNY
Sanofi says Qfitlia, Cablivi approved in China for rare hematologic diseases
Premium
The Fly
Sanofi says Qfitlia, Cablivi approved in China for rare hematologic diseases
17d ago
SNY
Sanofi price target lowered to EUR 100 from EUR 102 at HSBC
Premium
The Fly
Sanofi price target lowered to EUR 100 from EUR 102 at HSBC
18d ago
SNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >